GPS Wealth Strategies Group LLC Raises Position in Axon Enterprise, Inc. (NASDAQ:AXON)

GPS Wealth Strategies Group LLC grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 74.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 94 shares of the biotechnology company’s stock after purchasing an additional 40 shares during the period. GPS Wealth Strategies Group LLC’s holdings in Axon Enterprise were worth $56,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC boosted its stake in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP lifted its holdings in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC boosted its position in shares of Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise during the 3rd quarter valued at about $200,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Finally, Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Insider Activity

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 in the last three months. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $658.11 on Tuesday. The stock has a market cap of $50.18 billion, a price-to-earnings ratio of 170.05, a PEG ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $252.20 and a 12 month high of $698.67. The company’s 50 day moving average is $620.41 and its two-hundred day moving average is $486.16. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.